152 related articles for article (PubMed ID: 35949061)
1. AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.
Paoli C; Burel-Vandenbos F; Coulomb-l'Hermine A; Cros J; Pondrom M; Kubiniek V; Pedeutour F; Dadone-Montaudié B
Genes Chromosomes Cancer; 2022 Dec; 61(12):734-739. PubMed ID: 35949061
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.
Chmielecki J; Hutchinson KE; Frampton GM; Chalmers ZR; Johnson A; Shi C; Elvin J; Ali SM; Ross JS; Basturk O; Balasubramanian S; Lipson D; Yelensky R; Pao W; Miller VA; Klimstra DS; Stephens PJ
Cancer Discov; 2014 Dec; 4(12):1398-405. PubMed ID: 25266736
[TBL] [Abstract][Full Text] [Related]
3. A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.
Wang L; Basturk O; Wang J; Benayed R; Middha S; Zehir A; Linkov I; Rao M; Aryeequaye R; Cao L; Chmielecki J; Ross J; Stephens PJ; Adsay V; Askan G; Balci S; Klimstra DS
Mod Pathol; 2018 Jan; 31(1):132-140. PubMed ID: 28884748
[TBL] [Abstract][Full Text] [Related]
4. BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation.
Ghosh T; Greipp PT; Knutson D; Kloft-Nelson S; Jenkins S; Mounajjed T; Said S; La Rosa S; Vanoli A; Sessa F; Naini BV; Bellizzi A; Zhang L; Kerr SE; Graham RP
Arch Pathol Lab Med; 2022 Jul; 146(7):840-845. PubMed ID: 34614142
[TBL] [Abstract][Full Text] [Related]
5. RAF1 rearrangements are common in pancreatic acinar cell carcinomas.
Prall OWJ; Nastevski V; Xu H; McEvoy CRE; Vissers JHA; Byrne DJ; Takano E; Yerneni S; Ellis S; Green T; Mitchell CA; Murray WK; Scott CL; Grimmond SM; Hofmann O; Papenfuss A; Kee D; Fellowes A; Brown IS; Miller G; Kumarasinghe MP; Perren A; Nahm CB; Mittal A; Samra J; Ahadi M; Fox SB; Chou A; Gill AJ
Mod Pathol; 2020 Sep; 33(9):1811-1821. PubMed ID: 32358589
[TBL] [Abstract][Full Text] [Related]
6. RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas.
Chou A; Brown IS; Kumarasinghe MP; Perren A; Riley D; Kim Y; Pajic M; Steinmann A; Rathi V; Jamieson NB; Verheij J; van Roessel S; Nahm CB; Mittal A; Samra J; Gill AJ
Mod Pathol; 2020 Apr; 33(4):657-664. PubMed ID: 31558784
[TBL] [Abstract][Full Text] [Related]
7. Successful BRAF/MEK inhibition in a patient with
Busch E; Kreutzfeldt S; Agaimy A; Mechtersheimer G; Horak P; Brors B; Hutter B; Fröhlich M; Uhrig S; Mayer P; Schröck E; Stenzinger A; Glimm H; Jäger D; Springfeld C; Fröhling S; Zschäbitz S
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843432
[TBL] [Abstract][Full Text] [Related]
8. BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma.
Chou A; Kim Y; Samra JS; Pajic M; Gill AJ
Pathology; 2018 Apr; 50(3):345-348. PubMed ID: 29506751
[No Abstract] [Full Text] [Related]
9. Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature.
von Fritsch L; von Bubnoff N; Weber K; Kirfel J; Schreiber C; Keck T; Wellner U
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23222. PubMed ID: 38340027
[TBL] [Abstract][Full Text] [Related]
10. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
Al-Hader A; Al-Rohil RN; Han H; Von Hoff D
World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370
[TBL] [Abstract][Full Text] [Related]
12. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
Sun T; Gilani S; Jain D; Cai G
Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
[TBL] [Abstract][Full Text] [Related]
13. Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
Rankin A; Johnson A; Roos A; Kannan G; Knipstein J; Britt N; Rosenzweig M; Haberberger J; Pavlick D; Severson E; Vergilio JA; Squillace R; Erlich R; Sathyan P; Cramer S; Kram D; Ross J; Miller V; Reddy P; Alexander B; Ali SM; Ramkissoon S
Oncologist; 2021 Jan; 26(1):e153-e163. PubMed ID: 32918774
[TBL] [Abstract][Full Text] [Related]
14.
Kulkarni A; Al-Hraishawi H; Simhadri S; Hirshfield KM; Chen S; Pine S; Jeyamohan C; Sokol L; Ali S; Teo ML; White E; Rodriguez-Rodriguez L; Mehnert JM; Ganesan S
Clin Cancer Res; 2017 Sep; 23(18):5631-5638. PubMed ID: 28539463
[No Abstract] [Full Text] [Related]
15.
Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
[No Abstract] [Full Text] [Related]
16. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
[TBL] [Abstract][Full Text] [Related]
17. AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma.
Cordioli MI; Moraes L; Carvalheira G; Sisdelli L; Alves MT; Delcelo R; Monte O; Longui CA; Cury AN; Cerutti JM
Cancer Med; 2016 Jul; 5(7):1535-41. PubMed ID: 27037835
[TBL] [Abstract][Full Text] [Related]
18. Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.
Green BL; Grant RRC; Richie CT; Chatterjee B; Sampaio De Melo M; Barr FG; Pacak K; Agarwal SK; Nilubol N
Eur J Endocrinol; 2022 Jul; 187(1):185-196. PubMed ID: 35861986
[TBL] [Abstract][Full Text] [Related]
19. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.
Torrence D; Xie Z; Zhang L; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2021 Dec; 60(12):789-795. PubMed ID: 34398495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
